What is he best known for?
The fields of study Yusuke Furukawa is best known for:
Yusuke Furukawa conducts interdisciplinary study in the fields of Cell biology and DNA through his research.
He performs integrative DNA and Cell biology research in his work.
He carries out multidisciplinary research, doing studies in Gene and Transcription factor.
Many of his studies on Biochemistry involve topics that are commonly interrelated, such as Apoptosis.
Many of his studies on Apoptosis apply to Biochemistry as well.
In his work, he performs multidisciplinary research in Molecular biology and Cell culture.
He performs integrative study on Cell culture and Molecular biology in his works.
Cancer research and Genetics are two areas of study in which he engages in interdisciplinary work.
In his work, he performs multidisciplinary research in Genetics and Cancer research.
His most cited work include:
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element (890 citations)
- Signal transduction of the human granulocyte-macrophage colony- stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins (290 citations)
- In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents (265 citations)
What are the main themes of his work throughout his whole career to date
Many of his research projects under Receptor are closely connected to Cell biology with Cell biology, tying the diverse disciplines of science together.
His Apoptosis research extends to the thematically linked field of Biochemistry.
Much of his study explores Cell biology relationship to Stem cell.
In his articles, he combines various disciplines, including Stem cell and Haematopoiesis.
His research on Gene expression and Cell cycle is centered around Gene.
Yusuke Furukawa integrates Gene expression with Gene in his research.
In his works, he conducts interdisciplinary research on Cancer research and Genetics.
He performs multidisciplinary study in the fields of Genetics and Cancer research via his papers.
Yusuke Furukawa merges Molecular biology with Cell culture in his study.
Yusuke Furukawa most often published in these fields:
- Cell biology (46.67%)
- Biochemistry (46.67%)
- Cancer research (42.67%)
What were the highlights of his more recent work (between 2018-2022)?
- Internal medicine (55.56%)
- Immunology (44.44%)
- Cancer research (44.44%)
In recent works Yusuke Furukawa was focusing on the following fields of study:
Yusuke Furukawa combines Internal medicine and Dermatology in his research.
In his study, Yusuke Furukawa carries out multidisciplinary Immunology and Hematology research.
He applies his multidisciplinary studies on Cancer research and Somatic evolution in cancer in his research.
Borrowing concepts from Cancer research, he weaves in ideas under Somatic evolution in cancer.
In his research, he performs multidisciplinary study on Multiple myeloma and Carfilzomib.
Yusuke Furukawa integrates several fields in his works, including Carfilzomib and Proteasome inhibitor.
Yusuke Furukawa undertakes multidisciplinary studies into Proteasome inhibitor and Cancer in his work.
His work often combines Cancer and Multiple myeloma studies.
He connects Gene with Evolutionary biology in his research.
Between 2018 and 2022, his most popular works were:
- Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7 (36 citations)
- Molecular basis of clonal evolution in multiple myeloma (35 citations)
- Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients (12 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
